Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
filingDate |
2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bdb639132abbadbb86ffa603c83ded7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_246257bf41b665e8ecdfbb63ffc39d87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ad3f30281f91f0b9a0df681aa6d39df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4b1089d6a531727bb55b00173ad6aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70656a114f18fdbbb2b65319f8b80fb0 |
publicationDate |
2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3091995-A1 |
titleOfInvention |
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives |
abstract |
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed. In particular the application is directed to a pharmaceutical formulation comprising (a), at least one analogue and/or derivative of insulin; and (b). Zn(ll); and (c). sorbitol; and (d). optionally protamine. |
priorityDate |
2014-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |